Marjon Elfferich

1.2k total citations
21 papers, 839 citations indexed

About

Marjon Elfferich is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marjon Elfferich has authored 21 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 17 papers in Pulmonary and Respiratory Medicine and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marjon Elfferich's work include Sarcoidosis and Beryllium Toxicity Research (19 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers) and Occupational exposure and asthma (8 papers). Marjon Elfferich is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (19 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers) and Occupational exposure and asthma (8 papers). Marjon Elfferich collaborates with scholars based in Netherlands, United States and Australia. Marjon Elfferich's co-authors include Marjolein Drent, Jolanda De Vries, Petal A. Wijnen, Bert Strookappe, Patty J. Nelemans, Robert P. Baughman, Elyse E. Lower, Rudolf Ponds, Rik Marcellis and Kathrin I. Foerster and has published in prestigious journals such as European Respiratory Journal, Respiratory Medicine and Respiration.

In The Last Decade

Marjon Elfferich

21 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjon Elfferich Netherlands 18 619 614 117 96 76 21 839
Albert S. Rohr United States 15 260 0.4× 319 0.5× 37 0.3× 77 0.8× 34 0.4× 32 728
Thiago Thomáz Mafort Brazil 13 304 0.5× 180 0.3× 52 0.4× 16 0.2× 22 0.3× 55 648
Salvatore Fuschillo Italy 15 455 0.7× 310 0.5× 35 0.3× 16 0.2× 13 0.2× 51 744
Christine O’Brien United States 9 351 0.6× 125 0.2× 45 0.4× 16 0.2× 45 0.6× 10 621
Matthew Fenchel United States 18 488 0.8× 486 0.8× 139 1.2× 14 0.1× 8 0.1× 44 1.1k
Vildan Sümbüloğlu Türkiye 12 81 0.1× 121 0.2× 37 0.3× 29 0.3× 46 0.6× 25 639
William M. OʼNeill United Kingdom 15 106 0.2× 96 0.2× 97 0.8× 49 0.5× 36 0.5× 29 676
Yunsoo Soh South Korea 15 49 0.1× 206 0.3× 40 0.3× 44 0.5× 34 0.4× 44 550
H Poppius Finland 14 480 0.8× 427 0.7× 67 0.6× 24 0.3× 31 0.4× 62 756
Carla Daltro Brazil 16 100 0.2× 243 0.4× 48 0.4× 6 0.1× 55 0.7× 58 641

Countries citing papers authored by Marjon Elfferich

Since Specialization
Citations

This map shows the geographic impact of Marjon Elfferich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjon Elfferich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjon Elfferich more than expected).

Fields of papers citing papers by Marjon Elfferich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjon Elfferich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjon Elfferich. The network helps show where Marjon Elfferich may publish in the future.

Co-authorship network of co-authors of Marjon Elfferich

This figure shows the co-authorship network connecting the top 25 collaborators of Marjon Elfferich. A scholar is included among the top collaborators of Marjon Elfferich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjon Elfferich. Marjon Elfferich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drent, Marjolein, et al.. (2020). Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis. Lung. 198(2). 395–403. 21 indexed citations
2.
Drent, Marjolein, et al.. (2020). Benefit of Wearing an Activity Tracker in Sarcoidosis. Journal of Personalized Medicine. 10(3). 97–97. 18 indexed citations
3.
Baughman, Robert P., Elyse E. Lower, Paola Rottoli, et al.. (2020). Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire.. PubMed. 37(4). e2020009–e2020009. 23 indexed citations
4.
Drent, Marjolein, et al.. (2019). Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients. Lung. 197(5). 551–558. 30 indexed citations
5.
Voortman, Mareye, Marjon Elfferich, Francesco Bonella, et al.. (2019). The Burden of Sarcoidosis Symptoms from a Patient Perspective. Lung. 197(2). 155–161. 54 indexed citations
6.
Saketkoo, Lesley Ann, et al.. (2019). Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability. Lung. 197(4). 407–413. 29 indexed citations
7.
Voortman, Mareye, et al.. (2019). Everyday cognitive failure in patients suffering from neurosarcoidosis.. PubMed. 36(1). 2–10. 19 indexed citations
8.
Drent, Marjolein, et al.. (2018). The Fatigue Assessment Scale. Current Opinion in Pulmonary Medicine. 24(5). 495–503. 85 indexed citations
9.
Drent, Marjolein, et al.. (2017). Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: A prospective follow-up study. Respiratory Medicine. 138. S24–S30. 43 indexed citations
10.
Strookappe, Bert, et al.. (2016). Predictors of fatigue in sarcoidosis: The value of exercise testing. Respiratory Medicine. 116. 49–54. 27 indexed citations
11.
Strookappe, Bert, Lesley Ann Saketkoo, Marjon Elfferich, et al.. (2016). Physical activity and training in sarcoidosis: review and experience-based recommendations. Expert Review of Respiratory Medicine. 10(10). 1057–1068. 28 indexed citations
12.
Strookappe, Bert, et al.. (2015). Benefits of Physical Training in Sarcoidosis. Lung. 193(5). 701–708. 42 indexed citations
13.
Strookappe, Bert, et al.. (2015). Benefits of physical training in patients with sarcoidosis. PA831–PA831. 2 indexed citations
14.
Strookappe, Bert, et al.. (2015). Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study.. PubMed. 32(1). 43–52. 30 indexed citations
15.
Cremers, Johanna P., Marjolein Drent, Marjon Elfferich, et al.. (2013). Body composition profiling in a Dutch sarcoidosis population.. PubMed. 30(4). 289–99. 17 indexed citations
16.
Marcellis, Rik, et al.. (2011). Exercise capacity, muscle strength and fatigue in sarcoidosis. European Respiratory Journal. 38(3). 628–634. 94 indexed citations
17.
Elfferich, Marjon, Jolanda De Vries, & Marjolein Drent. (2011). Type D or 'distressed' personality in sarcoidosis and idiopathic pulmonary fibrosis.. PubMed. 28(1). 65–71. 27 indexed citations
18.
Elfferich, Marjon, Patty J. Nelemans, Rudolf Ponds, et al.. (2010). Everyday Cognitive Failure in Sarcoidosis: The Prevalence and the Effect of Anti-TNF-α Treatment. Respiration. 80(3). 212–219. 113 indexed citations
19.
Vries, Jolanda De, et al.. (2009). Fatigue in sarcoidosis: a systematic review. Current Opinion in Pulmonary Medicine. 15(5). 499–506. 79 indexed citations
20.
Elfferich, Marjon, et al.. (2009). Fatigue in sarcoidosis: American versus Dutch patients.. PubMed. 26(2). 92–7. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026